Toho Holdings Co., Ltd. Reports Consolidated Earnings Results for the Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the Period Ending September 2019 and March 2020
August 01, 2019 at 07:00 am
Share
Toho Holdings Co., Ltd. reported consolidated earnings results for the quarter ended June 30, 2019. For the quarter, the company reported net sales of JPY 312,522 million as compared to JPY 301,349 million for the same period last year. Operating profit was JPY 3,420 million as compared to JPY 2,051 million for the same period last year. Ordinary profit was JPY 5,034 million as compared to JPY 3,596 million for the same period last year. Profit attributable to owners of parent was JPY 3,413 million as compared to JPY 2,292 million for the same period last year. Basic earnings per share was JPY 50.08 as compared to JPY 33.59 for the same period last year. Diluted earnings per share was JPY 43.80 as compared to JPY 30.30 for the same period last year.
For the period ending September 2019, the company expects net sales of JPY 587,000 million, operating profit of JPY 5,800 million, ordinary profit of JPY 8,700 million, profit attributable to owners of parent of JPY 5,500 million and basic earnings per share of JPY 80.70.
For the period ending March 2020, the company expects net sales of JPY 1,223,000 million, operating profit of JPY 15,000 million, ordinary profit of JPY 21,800 million, profit attributable to owners of parent of JPY 13,600 million and basic earnings per share of JPY 199.56.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
Toho Holdings Co., Ltd. Reports Consolidated Earnings Results for the Quarter Ended June 30, 2019; Provides Consolidated Earnings Guidance for the Period Ending September 2019 and March 2020